ZimVie (ZIMV) Competitors

SI-BONE (NASDAQ:SIBN) and ZimVie (NASDAQ:ZIMV) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, community ranking, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership.

Does the MarketBeat Community believe in SIBN or ZIMV?

SI-BONE received 169 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 69.17% of users gave SI-BONE an outperform vote while only 27.27% of users gave ZimVie an outperform vote.

Company	Underperform	Outperform
SI-BONE	Outperform Votes 175 69.17%	Underperform Votes 78 30.83%
ZimVie	Outperform Votes 6 27.27%	Underperform Votes 16 72.73%

Which has preferable valuation and earnings, SIBN or ZIMV?

SI-BONE has higher earnings, but lower revenue than ZimVie. SI-BONE is trading at a lower price-to-earnings ratio than ZimVie, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SI-BONE	$176.60M	4.61	-$43.34M	-$0.64	-29.88
ZimVie	$443.55M	0.53	-$393.28M	-$0.71	-12.00

Is SIBN or ZIMV more profitable?

SI-BONE has a net margin of -23.82% compared to ZimVie's net margin of -77.31%. ZimVie's return on equity of 2.90% beat SI-BONE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SI-BONE	-23.82%	-22.51%	-16.53%
ZimVie	-77.31%	2.90%	1.17%

Do institutionals & insiders have more ownership in SIBN or ZIMV?

98.1% of SI-BONE shares are held by institutional investors. Comparatively, 95.6% of ZimVie shares are held by institutional investors. 4.0% of SI-BONE shares are held by insiders. Comparatively, 3.0% of ZimVie shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Does the media prefer SIBN or ZIMV?

In the previous week, SI-BONE had 12 more articles in the media than ZimVie. MarketBeat recorded 16 mentions for SI-BONE and 4 mentions for ZimVie. SI-BONE's average media sentiment score of 0.42 beat ZimVie's score of 0.42 indicating that SI-BONE is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SI-BONE	8 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ZimVie	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more volatility and risk, SIBN or ZIMV?

SI-BONE has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.16, meaning that its share price is 116% more volatile than the S&P 500.

Do analysts rate SIBN or ZIMV?

SI-BONE presently has a consensus target price of $22.50, indicating a potential upside of 17.68%. ZimVie has a consensus target price of $16.33, indicating a potential upside of 91.71%. Given ZimVie's higher possible upside, analysts clearly believe ZimVie is more favorable than SI-BONE.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SI-BONE	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
ZimVie	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.67

Summary

SI-BONE beats ZimVie on 12 of the 19 factors compared between the two stocks.